IMC-Chicago, LLC - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 6 filers reported holding REGENERON PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IMC-Chicago, LLC ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$21,808,440
-48.9%
26,500
-55.4%
0.02%
-51.3%
Q2 2023$42,681,276
+108.6%
59,400
+138.6%
0.04%
+62.5%
Q1 2023$20,459,583
+68.8%
24,900
+48.2%
0.02%
+26.3%
Q4 2022$12,121,032
-16.6%
16,800
-20.4%
0.02%0.0%
Q3 2022$14,535,000
+22.4%
21,100
+12.2%
0.02%
+90.0%
Q4 2021$11,873,000
+0.7%
18,800
-10.9%
0.01%
-28.6%
Q2 2021$11,785,000
-28.4%
21,100
-39.4%
0.01%
-41.7%
Q1 2021$16,465,000
-70.0%
34,800
-69.4%
0.02%
-65.7%
Q4 2020$54,881,000
+174.6%
113,600
+218.2%
0.07%
+118.8%
Q3 2020$19,984,000
+8.6%
35,700
+21.0%
0.03%
-15.8%
Q2 2020$18,398,000
-24.8%
29,500
-41.1%
0.04%
-25.5%
Q1 2020$24,463,000
+87.2%
50,100
+44.0%
0.05%
+50.0%
Q4 2019$13,067,000
+198.1%
34,800
+120.3%
0.03%
+142.9%
Q3 2019$4,383,000
-57.0%
15,800
-51.5%
0.01%
-57.6%
Q2 2019$10,204,000
+55.3%
32,600
+103.8%
0.03%
+37.5%
Q1 2019$6,570,000
-15.8%
16,000
-23.4%
0.02%0.0%
Q4 2018$7,806,00020,9000.02%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q1 2022
NameSharesValueWeighting ↓
Garda Capital Partners LP 3,500$2,880,3600.13%
GROUP ONE TRADING, L.P. 31,900$26,252,4240.09%
SIMPLEX TRADING, LLC 33,500$27,5690.02%
IMC-Chicago, LLC 26,500$21,808,4400.02%
Allianz Asset Management GmbH 12,400$10,204,7040.02%
SG Americas Securities, LLC 16,700$1,1420.01%
JANE STREET GROUP, LLC 42,400$34,893,5040.01%
JPMORGAN CHASE & CO 32,900$27,075,3840.00%
Focused Wealth Management, Inc 400$12,4410.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders